JEVITY 1.2 CAL OTC
Generic Name and Formulations:
Protein (sodium and calcium caseinate, soy protein isolate), carbohydrates (corn maltodextrin, corn syrup solids, fructooligosaccharides, fiber blend), fat (high oleic safflower, canola, MCT), fiber (soy, oat, gum arabic, carboxymethylcellulose); L-carnitine, taurine, vitamins, minerals; lactose- and gluten-free; contains milk and soy.
Indications for JEVITY 1.2 CAL:
Supplemental or sole-source tube feeding. May use orally in patients with altered taste perception.
Adults and Children:
Provides 285Cal/8oz (1200Cal/L).
High-protein medical nutritional supplement w. fiber.
Jevity 1 Cal (cans)—8oz, 32oz
Jevity 1.2 Cal, Jevity 1.5 Cal (cans)—8oz
Clinical Pain Advisor Articles
- Chronic Neuropathic Pain Updated Classification by IASP for ICD-11
- Buprenorphine-Naloxone Found to Be More Cost-Effective Than Extended-Release Naltrexone
- Ultrasound-Guided C2 Coblation May Be Effective for Cervicogenic Headache
- Meta-Analysis of Opioid Treatment for Chronic Noncancer Pain
- Opioids Found to Increase Risk for Community-Acquired Pneumonia, Particularly in HIV
- Reviewing the Use of Buprenorphine in Perioperative Pain Management
- Early Physical Therapy for Musculoskeletal Pain May Reduce Opioid Use
- External Trigeminal Nerve Stimulation May Alleviate Migraine Pain
- IASP Updates Diagnosis Criteria for Chronic Primary Pain for ICD-11
- Galcanezumab Provides Persistent Preventive Effects in Episodic, Chronic Migraine
- Comparable Analgesia With Low-Dose IV Ketamine, Morphine for Acute Pain
- Benzodiazepines, if Prescribed, May Not Affect Methadone Treatment Retention
- When Opioid Prescribing Guidelines Become Rules
- IV Fluid Confers No Significant Treatment Effect on Migraine Pain
- American Headache Society Releases Position Statement on Novel Preventive and Acute Migraine Treatments